Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000651366 | SCV000773217 | likely benign | Congenital myasthenic syndrome 8 | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003953184 | SCV004785811 | likely benign | AGRN-related condition | 2023-02-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Department of Neurology, |
RCV000651366 | SCV001916959 | pathogenic | Congenital myasthenic syndrome 8 | 2021-09-22 | no assertion criteria provided | clinical testing | |
Genome |
RCV003483703 | SCV004228715 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Likely benign and reported on 03-04-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |